Art

J-GLOBAL ID：201702276545184235   Reference number：17A1363205

Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy

癌免疫療法の有効性を改善する有望な標的としてのインターロイキン-6/STAT3シグナル伝達

Author (10)： Kitamura Hidemitsu (Division of Functional Immunology, Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan) ,  Ohno Yosuke (Division of Functional Immunology, Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan) ,  Ohno Yosuke (Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan) ,  Toyoshima Yujiro (Division of Functional Immunology, Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan) ,  Toyoshima Yujiro (Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan) ,  Ohtake Junya (Division of Functional Immunology, Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan) ,  Homma Shigenori (Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan) ,  Kawamura Hideki (Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan) ,  Takahashi Norihiko (Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan) ,  Taketomi Akinobu (Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan)
Material： Cancer Science (Web)  (Cancer Sci (Web))
Volume： 108  Issue： 10  Page： 1947-1952  Publication year： 2017 
JST Material Number： U0505A  ISSN： 1349-7006  Document type： Article
Article type： 文献レビュー  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： immunotherapy ,...
Semi thesaurus term： STAT3 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1363205&from=J-GLOBAL&jstjournalNo=U0505A") }}

Author keywords (5)： Cancer immunotherapy ,  dendritic cell ,  immunosuppression ,  interleukin-6 ,  STAT 3

JST classification (2)： Basic oncology in general  (GE02010R) ,  Tumors(=neoplasms)of digestive system  (GH04000D)

Reference (70)：

• van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643-7.
• Coulie PG, Van den Eynde BJ, van der Bruggen P et al. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat Rev Cancer 2014; 14: 135-46.
• Kumai T, Kobayashi H, Harabuchi Y et al. Peptide vaccines in cancer-old concept revisited. Curr Opin Immunol 2016; 8(45): 1-7.
• Yang JC, Rosenberg SA. Adoptive T-cell therapy for cancer. Adv Immunol 2016; 130: 279-94.
• Takeuchi Y, Nishikawa H. Roles of regulatory T cells in cancer immunity. Int Immunol 2016; 28: 401-9.

Terms in the title (6)： 癌免疫療法 ,  有効性 ,  標的 ,  インターロイキン-6 ,  STAT3 ,  シグナル伝達